Showing results (11-20 of 40) with videos related to

Sort By:
Pageof 4
Pain|October 1, 2019
Adoptive immunotherapy with autologous T-cell infusions reduces opioid requirements in advanced cancer patientsXinna Zhou, Guoliang Qiao, Jun Ren, et al.
American Journal of Cancer Research|January 8, 2021
Infiltration of metastatic lymph nodes with PD-1+ T cells is associated with improved disease-free and overall survival in resected N+ NSCLCShuo Wang, Yuguang Song, Michael A Morse, et al.
American Journal of Translational Research|August 11, 2020
Clinical efficacy of intra-cavitary infusions of autologous dendritic cell/cytokine-induced killer cell products for the treatment of refractory malignant pleural effusions and ascitesZixuan He, Shuo Wang, Guoliang Qiao, et al.
International Journal of Radiation Oncology, Biology, Physics|May 11, 2021
Changes in Peripheral Blood Regulatory T Cells and IL-6 and IL-10 Levels Predict Response of Pediatric Medulloblastoma and Germ Cell Tumors With Residual or Disseminated Disease to Craniospinal IrradiationLinan Song, Shuo Wang, Tong Fang, et al.
Journal of Thrombosis and Thrombolysis|March 24, 2019
Prospective randomized comparative study on rivaroxaban and LMWH for prophylaxis of post-apheresis thrombosis in adoptive T cell immunotherapy cancer patientsXiaoli Wang, Shuo Wang, Michael A Morse, et al.
Clinical Breast Cancer|May 19, 2019
Functional CD3+CD8+PD1- T Cell Accumulation and PD-L1 Expression Increases During Tumor Invasion in DCIS of the BreastShuzhen Lv, Shuo Wang, Guoliang Qiao, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|October 11, 2017
In Vivo Detection of HSP90 Identifies Breast Cancers with Aggressive BehaviorTakuya Osada, Kensuke Kaneko, William R Gwin, et al.
Journal of Translational Medicine|September 8, 2007
Long term disease-free survival and T cell and antibody responses in women with high-risk Her2+ breast cancer following vaccination against Her2Michael A Morse, Amy Hobeika, Takuya Osada, et al.
Journal of Immunotherapy (Hagerstown, Md. : 1997)|April 4, 2015
Precision cancer immunotherapy: optimizing dendritic cell-based strategies to induce tumor antigen-specific T-cell responses against individual patient tumorsTakuya Osada, Koji Nagaoka, Masashi Takahara, et al.
Nature Communications|June 13, 2022
Gene expression signatures of individual ductal carcinoma in situ lesions identify processes and biomarkers associated with progression towards invasive ductal carcinomaClare A Rebbeck, Jian Xian, Susanne Bornelöv, et al.
Pageof 4